Management of hilar cholangiocarcinoma in the North of England: Pathology, treatment, and outcome
Open Access
- 1 January 2005
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 11 (48) , 7625-7630
- https://doi.org/10.3748/wjg.v11.i48.7625
Abstract
Management of hilar cholangiocarcinoma in the North of England: Pathology, treatment, and outcomeKeywords
This publication has 37 references indexed in Scilit:
- Long-term outcome in patients with advanced hilar bile duct tumors undergoing palliative endoscopic or percutaneous drainageZeitschrift für Gastroenterologie, 2000
- One hundred and eleven liver resections for hilar bile duct cancerJournal of Hepato-Biliary-Pancreatic Surgery, 2000
- Surgery for hilar cholangiocarcinoma: an Italian experienceJournal of Hepato-Biliary-Pancreatic Surgery, 2000
- Surgery for hilar cholangiocarcinoma: the Johns Hopkins approachJournal of Hepato-Biliary-Pancreatic Surgery, 2000
- Surgical treatment for hilar cholangiocarcinomaJournal of Hepato-Biliary-Pancreatic Surgery, 2000
- Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapyBritish Journal of Surgery, 1995
- Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumoursEuropean Journal Of Cancer, 1995
- Indications for liver transplantation in hepatobiliary malignancyHepatology, 1994
- Indications for liver transplantation in hepatobiliary malignancyHepatology, 1994
- Epirubicin-Sequential Methotrexate-5-Fluorouracil-Leucovorin Treatment in Advanced Cancer of the Extrahepatic Biliary SystemAmerican Journal of Clinical Oncology, 1994